Jones Financial Companies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Buy
13,121
+5,279
+67% +$50.9K ﹤0.01% 2610
2026
Q1
$56.4K Buy
7,842
+7,162
+1,053% +$75.4K ﹤0.01% 2907
2025
Q4
$8K Buy
680
+176
+35% +$1.9K ﹤0.01% 3320
2025
Q3
$4K Buy
504
+64
+15% +$448 ﹤0.01% 3441
2025
Q2
$3.16K Buy
440
+60
+16% +$484 ﹤0.01% 3306
2025
Q1
$3.66K Buy
380
+287
+309% +$3.58K ﹤0.01% 3060
2024
Q4
$1.53K Buy
93
+32
+52% +$497 ﹤0.01% 3062
2024
Q3
$885 Buy
+61
New +$954 ﹤0.01% 2830

Other funds holding NEO

Jones Financial Companies's NEO Position: Q2 2026 in Review

Jones Financial Companies increased its NeoGenomics (NEO) stake by 67% in Q2 2026, buying an estimated $50.9K and bringing the position to 13,121 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Jones Financial Companies first reported a position in NEO in Q3 2024 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Jones Financial Companies held 13,121 shares of NeoGenomics worth $186K as of Q2 2026.
  • Jones Financial Companies bought 5,279 NeoGenomics shares in Q2 2026, an estimated $50.9K.
  • NeoGenomics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2610 holding.
  • Jones Financial Companies first reported a position in NeoGenomics in Q3 2024 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.